ZNF283
gene geneOn this page
Summary
ZNF283 (zinc finger protein 283, HGNC:13077) is a protein-coding gene on chromosome 19q13.31, encoding Zinc finger protein 283 (Q8N7M2). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 284349 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 80 total
- MANE Select transcript:
NM_181845
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13077 |
| Approved symbol | ZNF283 |
| Name | zinc finger protein 283 |
| Location | 19q13.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000167637 |
| Ensembl biotype | protein_coding |
| Entrez | 284349 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 6 protein_coding, 3 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000324461, ENST00000586976, ENST00000588797, ENST00000588967, ENST00000590950, ENST00000591203, ENST00000593164, ENST00000593268, ENST00000618787, ENST00000650832
RefSeq mRNA: 2 — MANE Select: NM_181845
NM_001297752, NM_181845
CCDS: CCDS46097
Canonical transcript exons
ENST00000618787 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001344624 | 43828202 | 43828281 |
| ENSE00001344627 | 43827321 | 43827444 |
| ENSE00003481483 | 43835505 | 43835592 |
| ENSE00003556242 | 43831318 | 43831381 |
| ENSE00003751292 | 43846939 | 43852017 |
| ENSE00003756669 | 43833505 | 43833626 |
| ENSE00003784573 | 43837053 | 43837179 |
Expression profiles
Bgee: expression breadth ubiquitous, 176 present calls, max score 84.96.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.7884 / max 211.2955, expressed in 1526 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 176226 | 3.1083 | 1295 |
| 176227 | 1.6425 | 890 |
| 176225 | 0.9289 | 424 |
| 176228 | 0.0554 | 3 |
| 176231 | 0.0259 | 2 |
| 176229 | 0.0147 | 3 |
| 176230 | 0.0127 | 2 |
Top tissues by expression
249 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| adrenal tissue | UBERON:0018303 | 84.96 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.18 | gold quality |
| colonic epithelium | UBERON:0000397 | 83.28 | gold quality |
| cortical plate | UBERON:0005343 | 80.64 | gold quality |
| calcaneal tendon | UBERON:0003701 | 80.44 | gold quality |
| stromal cell of endometrium | CL:0002255 | 76.86 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 76.07 | gold quality |
| ganglionic eminence | UBERON:0004023 | 75.91 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 75.81 | gold quality |
| monocyte | CL:0000576 | 75.74 | gold quality |
| cerebellar cortex | UBERON:0002129 | 75.73 | gold quality |
| ventricular zone | UBERON:0003053 | 75.52 | gold quality |
| rectum | UBERON:0001052 | 75.51 | gold quality |
| leukocyte | CL:0000738 | 75.45 | gold quality |
| islet of Langerhans | UBERON:0000006 | 74.69 | gold quality |
| cerebellum | UBERON:0002037 | 74.12 | gold quality |
| left ovary | UBERON:0002119 | 73.87 | gold quality |
| gall bladder | UBERON:0002110 | 73.71 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 73.61 | gold quality |
| bone marrow cell | CL:0002092 | 73.58 | gold quality |
| apex of heart | UBERON:0002098 | 73.49 | gold quality |
| right atrium auricular region | UBERON:0006631 | 73.42 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 73.14 | gold quality |
| right ovary | UBERON:0002118 | 73.06 | gold quality |
| heart left ventricle | UBERON:0002084 | 73.04 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 72.97 | gold quality |
| body of uterus | UBERON:0009853 | 72.97 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 72.64 | gold quality |
| popliteal artery | UBERON:0002250 | 72.33 | gold quality |
| lower esophagus | UBERON:0013473 | 72.32 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6379 | no | 62.63 |
| E-ANND-3 | no | 5.85 |
| E-MTAB-5061 | no | 1.75 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
20 targeting ZNF283, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-3119 | 99.92 | 71.34 | 2390 |
| HSA-MIR-3941 | 99.86 | 70.54 | 2735 |
| HSA-MIR-451B | 99.55 | 68.28 | 1380 |
| HSA-MIR-513C-5P | 99.50 | 68.42 | 1730 |
| HSA-MIR-514B-5P | 99.50 | 68.19 | 1766 |
| HSA-MIR-580-5P | 99.28 | 70.94 | 1776 |
| HSA-MIR-5584-3P | 99.23 | 68.79 | 1351 |
| HSA-MIR-6768-3P | 99.14 | 67.38 | 1319 |
| HSA-MIR-6074 | 98.89 | 69.64 | 2187 |
| HSA-MIR-302F | 98.44 | 69.02 | 1776 |
| HSA-MIR-4457 | 98.09 | 67.12 | 1274 |
| HSA-MIR-1287-5P | 96.80 | 65.30 | 743 |
| HSA-MIR-382-5P | 96.71 | 65.90 | 762 |
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 283 — Q8N7M2 (reviewed: Q8N7M2)
Alternative names: Zinc finger protein HZF19
All UniProt accessions (5): A0A494C0U8, Q8N7M2, K7EL69, K7ESH0, Q4G0N1
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Tissue specificity. Detected in prostate, testis, and pancreas.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (2): NP_001284681, NP_862828* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352, PF13912
UniProt features (29 total): zinc finger region 15, sequence variant 5, sequence conflict 4, cross-link 3, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N7M2-F1 | 63.30 | 0.01 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3): 280, 476, 588
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 26 (showing top):
GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, ZWANG_DOWN_BY_2ND_EGF_PULSE, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, H1_6_TARGET_GENES, RYBP_TARGET_GENES, ZBTB12_TARGET_GENES, ZNF577_TARGET_GENES, MIR4262, MIR3941, MIR6074, MIR514B_5P, MIR513C_5P, MANNO_MIDBRAIN_NEUROTYPES_HNBML5, MANNO_MIDBRAIN_NEUROTYPES_HNBGABA, AIZARANI_LIVER_C30_HEPATOCYTES_4
GO Biological Process (3): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355), negative regulation of macromolecule biosynthetic process (GO:0010558)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| macromolecule biosynthetic process | 1 |
| negative regulation of biosynthetic process | 1 |
| regulation of macromolecule biosynthetic process | 1 |
| negative regulation of macromolecule metabolic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
460 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF283 | EFCAB13 | Q8IY85 | 382 |
| ZNF283 | ZNRF4 | Q8WWF5 | 311 |
| ZNF283 | DYM | Q7RTS9 | 311 |
| ZNF283 | ZMIZ2 | Q8NF64 | 310 |
| ZNF283 | SNX32 | Q86XE0 | 294 |
| ZNF283 | KRT6C | P48666 | 275 |
| ZNF283 | ZFAND3 | Q9H8U3 | 273 |
| ZNF283 | OR10S1 | Q8NGN2 | 266 |
| ZNF283 | ZNF503 | Q96F45 | 259 |
| ZNF283 | WDPCP | O95876 | 252 |
| ZNF283 | GINS3 | Q9BRX5 | 246 |
| ZNF283 | DCLRE1B | Q9H816 | 246 |
| ZNF283 | POLR2F | P41584 | 233 |
| ZNF283 | POLR2L | P52436 | 223 |
| ZNF283 | UBTFL1 | P0CB47 | 218 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CBX3 | KPNA4 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF283 | HSPA4L | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (1): ZNF283 (Affinity Capture-MS)
ESM2 similar proteins: A2VDQ7, A6NNF4, A8MQ14, A8MTY0, E9QAG8, O75290, O75373, P08043, P0CJ79, P10751, P17017, P17027, P17039, P35789, P51522, P51523, Q08AN1, Q14585, Q14587, Q3SYV7, Q3ZCX4, Q4R4C7, Q52M93, Q5MCW4, Q5R5U3, Q5R8X1, Q5R9F0, Q5SXM1, Q6ECI4, Q6JLC9, Q6P3V2, Q6P5C7, Q6ZN57, Q86UE3, Q86XN6, Q86YE8, Q8C827, Q8IYB9, Q8N4W9, Q8N7M2
Diamond homologs: A0A096LPI5, A6NIU2, A6NJG6, F2Z398, P0DTE4, P51957, Q09FC8, Q5H9K5, Q5T7P6, Q68CZ1, Q6B4Z3, Q6UX73, Q86U02, Q8IV13, Q8N7M2, Q8N9N2, Q8NDZ0, Q8NEM8, Q8TDM0, Q92918, Q96J02, Q96MD7, Q9BUA6, Q9NXG0, A0A1W2PQL4, A2RRD8, A2VDQ7, A6NHJ4, A6NK75, A6NN14, A6NNF4, A6NP11, B4DX44, B4DXR9, E9PW05, O14628, O43345, O75290, O75346, O75373
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
80 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 72 |
| Likely benign | 1 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1194 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:43828200:A:AG | acceptor_gain | 1.0000 |
| 19:43828200:A:AT | acceptor_loss | 1.0000 |
| 19:43828200:AGT:A | acceptor_gain | 1.0000 |
| 19:43828201:G:GC | acceptor_gain | 1.0000 |
| 19:43828201:GT:G | acceptor_gain | 1.0000 |
| 19:43828201:GTG:G | acceptor_gain | 1.0000 |
| 19:43828201:GTGC:G | acceptor_gain | 1.0000 |
| 19:43828201:GTGCT:G | acceptor_gain | 1.0000 |
| 19:43828277:TTCAG:T | donor_loss | 1.0000 |
| 19:43828278:TCAG:T | donor_loss | 1.0000 |
| 19:43828280:AG:A | donor_loss | 1.0000 |
| 19:43828282:G:GA | donor_loss | 1.0000 |
| 19:43828283:T:A | donor_loss | 1.0000 |
| 19:43835590:GAT:G | donor_gain | 1.0000 |
| 19:43835593:G:GG | donor_gain | 1.0000 |
| 19:43827870:G:GT | donor_gain | 0.9900 |
| 19:43827889:G:GT | donor_gain | 0.9900 |
| 19:43827929:G:GT | donor_gain | 0.9900 |
| 19:43827929:G:T | donor_gain | 0.9900 |
| 19:43828199:CAGTG:C | acceptor_gain | 0.9900 |
| 19:43828200:AGTGC:A | acceptor_gain | 0.9900 |
| 19:43828277:TTC:T | donor_gain | 0.9900 |
| 19:43828278:TCA:T | donor_gain | 0.9900 |
| 19:43828279:CAG:C | donor_gain | 0.9900 |
| 19:43831378:GCTG:G | donor_gain | 0.9900 |
| 19:43835503:A:AG | acceptor_gain | 0.9900 |
| 19:43835504:G:GA | acceptor_gain | 0.9900 |
| 19:43835504:GTTCT:G | acceptor_gain | 0.9900 |
| 19:43837047:TTTTA:T | acceptor_loss | 0.9900 |
| 19:43837048:TTTA:T | acceptor_loss | 0.9900 |
AlphaMissense
4558 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:43847835:T:C | F412L | 0.997 |
| 19:43847837:T:A | F412L | 0.997 |
| 19:43847837:T:G | F412L | 0.997 |
| 19:43847919:T:C | F440L | 0.997 |
| 19:43847921:T:A | F440L | 0.997 |
| 19:43847921:T:G | F440L | 0.997 |
| 19:43848255:T:C | F552L | 0.997 |
| 19:43848257:T:A | F552L | 0.997 |
| 19:43848257:T:G | F552L | 0.997 |
| 19:43847667:T:C | F356L | 0.996 |
| 19:43847669:C:A | F356L | 0.996 |
| 19:43847669:C:G | F356L | 0.996 |
| 19:43847751:T:C | F384L | 0.995 |
| 19:43847753:T:A | F384L | 0.995 |
| 19:43847753:T:G | F384L | 0.995 |
| 19:43848003:T:C | F468L | 0.995 |
| 19:43848005:T:A | F468L | 0.995 |
| 19:43848005:T:G | F468L | 0.995 |
| 19:43847499:T:C | F300L | 0.994 |
| 19:43847501:T:A | F300L | 0.994 |
| 19:43847501:T:G | F300L | 0.994 |
| 19:43848171:T:C | F524L | 0.994 |
| 19:43848173:T:A | F524L | 0.994 |
| 19:43848173:T:G | F524L | 0.994 |
| 19:43848274:T:C | L558P | 0.992 |
| 19:43848339:T:C | F580L | 0.992 |
| 19:43848341:C:A | F580L | 0.992 |
| 19:43848341:C:G | F580L | 0.992 |
| 19:43847686:T:C | L362P | 0.990 |
| 19:43847770:T:C | L390P | 0.990 |
dbSNP variants (sampled 300 via entrez): RS1000006143 (19:43833091 G>C,T), RS1000010560 (19:43838153 C>A,T), RS1000083483 (19:43837786 T>A), RS1000165739 (19:43843194 A>T), RS1000217692 (19:43842865 A>G), RS1000288894 (19:43830797 A>G), RS1000325039 (19:43835860 A>C,T), RS1000730363 (19:43829909 G>A), RS1000739837 (19:43829563 G>A), RS1001085093 (19:43836010 A>T), RS1001091970 (19:43843665 A>G), RS1001312395 (19:43843304 G>C), RS1001499519 (19:43836843 T>C), RS1001693412 (19:43839974 T>A), RS1001771281 (19:43836432 C>G,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001937_27 | Breast cancer | 2.000000e-10 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
14 total (human), top 14 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| TAK-243 | increases sumoylation | 1 |
| urushiol | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| jinfukang | decreases expression | 1 |
| Arsenic Trioxide | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Urethane | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
| Lactic Acid | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 induced pluripotent stem cell
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B5NP | PGPC3_75 | Induced pluripotent stem cell | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.